-
Mashup Score: 46
CROSSFIRE did not identify a difference in overall survival or incidence of adverse events between MRI-guided SABR and CT-guided percutaneous irreversible electroporation after FOLFIRINOX. Future studies should further assess the added value of local ablative treatment over chemotherapy alone.
Source: www.thelancet.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 40
CROSSFIRE did not identify a difference in overall survival or incidence of adverse events between MRI-guided SABR and CT-guided percutaneous irreversible electroporation after FOLFIRINOX. Future studies should further assess the added value of local ablative treatment over chemotherapy alone.
Source: www.thelancet.comCategories: General Medicine News, GastroenterologyTweet
New research - Timmer et al - MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer: the CROSSFIRE phase 2 trial https://t.co/rJHGOZbFiq #GITwittter #OncTwitter #PanCSM https://t.co/anKP5RquTT